Corbion has secured regulatory approvals from China’s General Administration of Customs (GACC) for its algae-derived Omega-3 DHA products in human and animal nutrition, thereby paving the way for its access into China’s fast-growing human and animal nutrition segments.
Corbion achieved several crucial registrations from GACC for its omega-3 products marketed under the AlgaPrime™ DHA and AlgaVia™ DHA brands. Both brands are premium algae-derived omega-3 products designed to meet the growing demand for high-quality animal nutrition as well as plant-based human nutrition and nutraceutical solutions in China.
Tim Rutten, Vice President Nutrition & Pharma at Corbion said, “With these registrations and licenses in place, we can now offer Chinese customers and partners our proven ingredients that align with their focus on quality, safety, and sustainability.”
Corbion’s AlgaVia™ DHA and AlgaPrime™ DHA deliver a clean, highly concentrated, and sustainable source of omega-3 DHA. They are produced on land from microalgae via controlled fermentation using sugar cane and renewable energy, thereby reducing reliance on marine resources and carbon footprint at the same time. Trusted by leading brands in human nutrition, aquaculture, livestock, and pet food, these solutions enhance omega-3 profiles and supply chain resilience amid rising global demand.
Apart from delivering quality omega-3 ingredients, Corbion also offers flexible solutions tailored to diverse customer needs. Whether in powder, liquid suspension, or oil format, its algae-based omega-3 solutions fit into a wide range of applications across human and animal nutrition.
For more information, click on: Corbion Purac Singapore Pte Ltd
